GTU-influenza vaccine

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameGTU-influenza vaccine
Drug Alias Namehemagglutinin/neuraminidase/m3 DNA vaccine (FIT Biotech/Epixis/Universite Pierre et Marie Curie)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFranceFinland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFIT Biotech Oyj Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A